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Abstract
Antimalarial chloroquine (CQ) prevents haematin detoxication when CQ-base concentrates
in the acidic digestive vacuole through protonation of its p-aminopyridine (pAP) basic aro-
matic nitrogen and sidechain diethyl-N. CQ export through the variant vacuolar membrane
export channel, PFCRT, causes CQ-resistance in Plasmodium falciparum but 3-methyl CQ
(sontochin SC), des-ethyl amodiaquine (DAQ) and bis 4-aminoquinoline piperaquine (PQ)
are still active. This is determined by changes in drug accumulation ratios in parasite lipid
(LAR) and in vacuolar water (VAR). Higher LAR may facilitate drug binding to and blocking
PFCRT and also aid haematin in lipid to bind drug. LAR for CQ is only 8.3; VAR is 143,482.
More hydrophobic SC has LAR 143; VAR remains 68,523. Similarly DAQ with a phenol sub-
stituent has LAR of 40.8, with VAR 89,366. In PQ, basicity of each pAP is reduced by distal
piperazine N, allowing very high LAR of 973,492, retaining VAR of 104,378. In another bis
quinoline, dichlorquinazine (DCQ), also active but clinically unsatisfactory, each pAP
retains basicity, being insulated by a 2-carbon chain from a proximal nitrogen of the single
linking piperazine. While LAR of 15,488 is still high, the lowest estimate of VAR approaches
4.9 million. DCQmay be expected to be very highly lysosomotropic and therefore potentially
hepatotoxic. In 11 pAP antimalarials a quadratic relationship between logLAR and logRe-
sistance Index (RI) was confirmed, while log (LAR/VAR) vs logRI for 12 was linear. Both
might be used to predict the utility of structural modifications.
Introduction
Early in the search for chloroquine (CQ) analogues, which could retain their antimalarial activ-
ity against the increasingly prevalent CQ-resistant strains [1] of Plasmodium falciparum, a
group of bis-quinolines was synthesized [2, 3]. Structurally they were made up of two 4-amino-
7-chloroquinoline units like CQ, 2, connected at the 4-amino site by a variable aliphatic linker
group containing carbon, nitrogen and sometimes oxygen atoms (Fig 1). Later, using simple
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alkyl linkers, in this type of bis-compound, branched chains or alicyclic bridges were shown to
have increased activity compared to straight chains, and this was ascribed to reduced confor-
mational mobility [4]. A similar inference may be drawn from the earlier use of two rigid cyclic
diamine 1,4 piperazine moieties as the linker, in compounds such as piperaquine (PQ) 13,228
RP [3], 3 which retain high activity against CQ-resistant P. falciparum [5] (Fig 1). A similar
bis-quinoline (6) also studied has as linker a single 1,4-bis- (propylpiperazine) unit (Fig 1).
This compound, as 12,278 RP [2], was reported active against both CQ-sensitive and resistant
P.berghei in mice [2, 3] though with lower efficacy on another CQ-resistant strain [6]. Named
dichlorquinazine (DCQ) by Schmidt et al. its activity against CQ-resistant strains of P. falcipa-
rum in monkeys was confirmed [7], and against field isolates in vitro, [8] but no mechanism-
directed studies have appeared since the agent was not found sufficiently effective clinically [9].
The selective toxicity of CQ (2) to the malaria parasite is believed to occur within the
infected erythrocyte, and specifically in the digestive vacuole of the parasite through binding to
haematin and preventing its detoxication to crystalline β-haematin (haemozoin) [10–12]. The
entry of a basic drug through lipid membranes and its distribution into the aqueous compart-
ments of an infected erythrocyte is determined by the lipid-water partition coefficient-
(expressed as Log P), as modified by pH through the ionization constants (pKa) of the basic
centre (s) of the drug to give the pH-modified coefficient Log D [13]. This raised the question
whether these two bis quinolines (3 and 6) of similar molecular weight (535 for 3 vs. 523 for 6)
may owe their biological properties to identical physicochemical parameters in respect of their
acid-base character and lipid solubility.
We therefore measured the pKa and log P values of DCQ, in comparison with those of PQ
and CQ. In addition, the activity of DCQ in the prevention of haematin detoxication by dimer-
ization to β-haematin (β-haematin inhibition assay: βHIA) has been determined, as was earlier
done for CQ, PQ, OHPQ and cpd 5 (a fragment of PQ) [13].
Material and Methods
Dichlorquinazine 6, 12,278 RP, was supplied by Rhone-Poulenc [14]. Since DCQ is centro-
symmetric and contains two chiral centres, it can exist in the optically active R,R or S,S form
{mp 250–251°C, [α]D + or -382° (MeOH)}, or in the non-resolvable meso (internally compen-
sated or RS) form with mp 270–271°C, [α]D + 0°. The present test material has mp 249–250°C
and [α]D + 0°, and was identified from its properties as a 1:1 mixture of the R,S and meso
forms (the expected synthesis product). (mp reported: 250°C) [14–15]. Analysis predicted
from composition C28H32CI2N6, would be: C, 64.24; H, 6.19; N, 16.06: found: C 64.4; H 6.30; N
15.93%. Samples of PQ 3 and OHPQ 4 were obtained fromWHO (Dr. Piero Olliaro and Dr.
Alan Shapiro) as the tetraphosphate tetrahydrate and CQ 2 was supplied as the racemic dis-
phosphate by Sigma, Cpd.5, 5 was synthesized as reported in [13].
Physicochemical
The partition coefficient (log P) is measured for the un-ionized drug. For partially ionized com-
pounds the partition coefficient at any fixed pH is called the distribution coefficient on the
assumption that only the un-ionized base partitions from the aqueous to the lipid phase [15].
At any given pH, logD is then obtained from Eq 1 [16–17]. The ionized basic centres of CQ 2
are (1) a resonance-stabilized aromatic amidinium ion made up of the protonated N-1 of the
quinoline and an amino group attached by a single bond to C-4 of the same ring, and (2) the
distal aliphatic protonated N. Thus Eq 1 needs modification to Eq 2. PQ 3, and DCQ 6 are cen-
tro-symmetric and have two of each type of basic centre. Initial protonation at one basic centre
may affect the other via a through-space electrostatic effect of the now positively charged N ion
Influence of LAR and VAR on Para-Aminopyridine Antimalarials
PLOS ONE | DOI:10.1371/journal.pone.0160091 August 2, 2016 2 / 11
Miscellaneous external analysis costs were paid
personally by these authors, but both have
acknowledged the continuing essential logistical
support of these distinguished research institutes.
Competing Interests: The authors have declared
that no competing interests exist.
on the other (uncharged) N atom, causing a slight reduction of the basicity of the second basic
centre by inhibiting its protonation. The existence of 4 separate pKa values for PQ and DCQ is
therefore possible, and to provide for the contribution from all ionized species to the log D, Eq
2 is modified to Eq 3. (see below).
logD ¼ logP  log½1þ 10ðpKapH ð1Þ
logD ¼ logP  log½1þ 10ðpKa1pHÞ þ 10ðpKa1þpKa22pHÞ ð2Þ
LAR ¼ antilog logD7:4; andVAR ¼ ½antilogðlogD7:4 logDpHVacÞ ð3Þ
It should be noted that in Eqs 2 and 3, pKa1 pKa2 pKa3 pKa4.
Eqs 1 and 2 and 3 make it possible to calculate log D from observed log P, pKa and pH [17].
As well as experimentally measuring log P, it can be estimated using the Clog P program devel-
oped by Hansch and Leo [16] and various modifications such as the ACD suite (www.acdlabs.
com/products/percepta/physchem/admetox/). Dissociation constants and partition coefficients
Fig 1. Structures of the main pAP compounds examined. Note outline (blue) of the p-aminopyridine
moiety in CQ(2) and its presence in Atebrin, ATB(1) and (5). Also note 2 pAPmoieties in each of (3), (4) and
(6). Compound (5), a half–piperaquine, has low antiparasitic activity and shows 6 times less activity in the in
vitro BIHA test than PQ (3) [14].
doi:10.1371/journal.pone.0160091.g001
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were experimentally determined by Robertson Microlit Laboratories (Madison NJ USA) at
25°C using the Sirius GLpK automated computerized potentiometric system [18] which is
capable of resolving ionization constants of multiprotic substances. Titration employed water
containing 0.15M KCl (representing a physiological concentration of positive and negative
counter-ions) in an argon atmosphere. The pKa values were determined in triplicate with a SE
of ± 0.20. For PQ 3 and DCQ 6 the base precipitated above pH 7.0. The titrations were there-
fore carried out with methanol as a co-solvent, using 5 different ratios of methanol to water.
The aqueous pKa was determined by extrapolation to 0% methanol [19] using the method of
Yashuda-Shedlovsky which gives a linear fit. LogD values at the physiological pH of 7.4 and at
pH 4.8 as previously used [13], were calculated from Eq 2 or Eq 3. Partition coefficients
between octanol and water were measured by dual-phase potentiometric titration using graded
amounts of water-saturated n-octanol. Titrant addition was carried out with vigorous stirring
of the assay solution. Three different ratios of octanol/water were employed for each com-
pound. The log P values were obtained from the difference between the aqueous pKa of the
species and the apparent pKa determined from the dual phase titration. Measurements were
carried out in triplicate with a S.E of ± 0.40. The potentiometric method was validated by com-
parison with results obtained by the standard shake-flask technique [19].
For a direct comparison between CQ, synthesized in 1930s Germany, and its replacement
sontochin (SC) its less toxic 3-methyl derivative (Fig 2), it was important to compare measured
values for both. We did not have access to SC and our first estimates were made entirely by cal-
culation and resulted in logD (7.4) of 2.024 and log D (4.8) of -2.268. Fortunately Irvin and
Irvin (1947) [20] had compared the pKa values of CQ and SC directly by titration using a tech-
nique closely similar to current practise and obtained pKa values for CQ of pKa1: 10.16 and
pKa2: 8.08 (our measured values had been 10.18 and 8.38). Their measurements for SC were
10.15 and 7.28, and were used in preference to those we calculated using the ACD suite, result-
ing in log D(7.4) of 2.15 and logD(4.8) of -2.68 (see Table 1 and S1 Table). The calculated Log
P values from ACD (based on CLog P [16]) are reliable when compared with measurement.
Molecular Modelling
Earlier we found molecular modelling using AM1 [13] helpful in interpreting stoichiometry of
interactions with haematin [13], and also to test expectations of resonance within the para (4)-
aminopyridine ring and the para-aminopyridinium ion formed on protonation of the aromatic
ring N1.
Structures and energies were calculated in vacuo (in view of our interest in lipid association)
in the Restricted Hartree- Foch (RHF) state, singly excited, with 15 occupied and 15 unoccu-
pied orbitals).
Results and Discussion
The original question was whether two bis quinolines (3 and 6) of similar molecular weight
(535 for 3 vs. 523 for 6) might owe their biological properties to identical physicochemical
parameters in respect of their acid-base character and lipid solubility. This is apparently true
only to a certain extent. The measured dissociation constants and log P, and the calculated and
measured log D values at pH 7.4 and 4.8 for compounds 1–6 are shown in Table 1. It is seen
that in 3, 4 and 6 stepwise protonation of the two quinoline ring N atoms can occur, resulting
in a small reduction of pKa for the second quinoline N due to the slight base-weakening effect
of the first protonated N. This is shown in DCQ 6 by the pKa1, and pKa2 values of 8.71 and
8.34 for the two aromatic para-aminopyridinium ions (Table 1 and S1 Table), in good agree-
ment with the value for CQ 2 (8.38). While the pKa for N-1 in piperazine itself is 9.81, alkyl
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substitution of a secondary N to become a tertiary N lowers its basic strength by ca. 1 pKa unit,
e.g. N (2-aminoethyl) piperazine has pKa of 8.51, and further alkyl substitution at N-4 brings it
to ca. 7.5, in agreement with the experimental 7.36 found for pKa3. In the case of piperazine,
the pKa of N-4 when N-1 is protonated is 5.5, i.e. prior protonation of N-1 here causes a much
larger base-weakening effect due to the close proximity of the two basic centres. This is in good
agreement with the observed value of 5.9 for this pKa for DCQ 6.
The results in Table 1 reveal that while the basic character of PQ 3 is affected to a major
extent (100-fold reduction in basic strength) by each piperazine-N-1 being also the 4-amino N
of each quinoline, in DCQ 6 each secondary N-4 para-aminopyridinium system of CQ remains
intact, with no change in pKa1 or pKa2 from that in CQ. On the other hand the more basic ter-
minal diethylamino group (pKa 10.18 in CQ 2) has been replaced in DCQ 6 by the much
weaker basic N-1 and N-4 of piperazine (pKa 7.36 and 5.90). This change in pKa characteristics
is indeed reflected in the observed values of logP (Table 1).
While the expected high lipophilicity of PQ 3 (log P: 6.11) is replicated in DCQ 6 (6.10), it
should be noted that log P reflects only the partition behaviour for the compound in the free
base state. At physiological pH values, the two compounds behave differently. For PQ 3 at pH
7.4, the measured logD of 5.99, is essentially unchanged from the log P value 6.11. However,
because mean pKa for DCQ 6 (ca. 8.5) is two units higher than that for PQ 3)(ca. 6.5), mea-
sured logD (pH 7.4) for DCQ 6 drops by 2 logs to 4.19 (calc. 3.54).
Our studies [13] of the antiplasmodial activity of PQ 3 suggested that retention of activity
against CQ-resistant strains of P. falciparum was linked to its enhanced lipophilic properties
indicating optimal membrane transfer at pH 7.4 into the lipid phase, together with a high
degree of accumulation in the acidic vacuolar water content, where its haematin interaction
capability (per quinoline pAP unit) equals that of CQ 2. While haematin in the parasite diges-
tive vacuole is a target of both PQ and CQ, a high concentration of drug in the digestive vacuole
water appears not to be enough for activity in CQ-resistance, since PQ 6 (and amodiaquine/
desethylamodiaquine) clearly concentrate within membrane or intravacuolar lipid droplets in
the infected erythrocyte and may also hydrophobically bind inside the export channel and
inhibit transport [21–25].
To some extent, the influence of the ionization behaviour of DCQ 6 on its intracellular dis-
tribution similarly determines its unusual biological properties. At physiological pH, with a
Fig 2. Structures of the German CQ (resochin) replacement sontochin (SC) and PH-203, a highly
active pAP recently developed from SC [20].
doi:10.1371/journal.pone.0160091.g002
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mean pKa of 8.55, the compound exists almost totally (>95%) as the mono-protonated quino-
linium salt (the same is true for CQ 2 with a pKa of 8.38). In addition, the proximal N-1 pipera-
zine nitrogen in DCQ 6 (pKa 7.36) is 50% ionized at pH 7.4 (the distal N-4 nitrogen with pKa
5.90 remains>95% in the free base form). The resultant loss in lipophilicity for DCQ 6
between log P and log D 7.4 is reflected in a decrease of 2 log units. (For CQ 2, its side-chain N
with pKa 10.18 is totally protonated at pH 7.4 and no longer makes a lipophilic contribution
compared with log P, resulting in a drop of almost 4 log units).
At pH 4.8, all basic centres of DCQ 6 are essentially totally ionized (100%, 100%, 83%
respectively). This is reflected in the drop of observed log D (pH 4.8) to -2.5. Differences
between the effect of drugs against CQ-resistant mutants may depend on the relationship
between LAR and VAR. Given an equal inhibitory effect on haematin dimerization and forma-
tion of hemozoin (β-hematin), value of VAR determines the effect on CQ-sensitive parasites
(Table 1 and S1 Table). However, as the hydrophobicity and accessibility of the CRT channel
in the CQ-R parasites increases, the interaction of the drug with the lining residues of the chan-
nel appears to be determined by the LAR [21, 22], and so a high LAR is preferable. Comparing
the VAR values of PQ 3 and DCQ 6, that of the latter drug is very much higher. Yet for activity
in CQ-resistant parasites high LAR values are apparently more important [13].
Although observed and calculated log D (pH 7.4) values for PQ 3 and DCQ 6 studied by
both Robertson Microlit and using Eq 3 are closely similar, at pH 4.8 there is over 2 orders of
magnitude difference between observed and calculated log D (pH4.8) values for DCQ 6 (-2.5
and -5.043) not seen for the less basic PQ 3 (0.97 and 1.02). This may reflect a difference in the
algorithm [16] used by Robertson Microlit Laboratories to estimate the acidic log D values (in
the protocol using the Sirius GlpKa machine), and is in contrast to Eqs (1–3) which we nor-
mally use to obtain log D from log P [13]. However in view of the mixed population of DCQ
structures contained in the test material, it could also reflect intermolecular association effects
or solubility problems not detected by our calculation.
On comparing log (LAR/VAR) with log DpH4.8, we realized that these values are identical.
This is true for any vacuolar pH, because[13]:
LAR ¼ antiloglogD7:4; andVAR ¼ ½antilogðlogD7:4  logDpHVacÞ:
Given suitably accurate values for the Log D value of a drug at pH 7.4 (log D (pH 7.4)) and at
the pH of water in the digestive vacuole of the malaria parasite (log D(pHVAC)), it is possible to
estimate the lipid accumulation ratio (LAR) of the drug:
LAR ¼ antilog logDðpH7:4Þ
and its accumulation into vacuolar water (VAR).
VAR ¼ antilog½ðlogDðpH7:4ÞÞ  ðlogDðpHVACÞ:
It also follows from this that the value of log(LAR/VAR) = (logD(pHVAC))
Molecular Modelling:
In Table 2. based on the AM1 calculation [13], we notice the similar short distance between N-1
and 4-amino N atoms in the diprotonated form, of CQ2H+ 2 and DCQ2H+ 6. This indicates a
marked resonance effect in both, which would predict their similar observed N-1 pKa values con-
trasting with the lower N-1 pKa values for PQ2H+. We found molecular modelling using AM1
[24] helpful in interpreting stoichiometry of interactions with haematin earlier [13], and here this
has been used to test expectations of resonance between the para-amino substituent of the pyri-
dine ring and the pyridinium ion formed on protonation of the aromatic ring N. The para-
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aminopyridinium ion is found in each quinoline (CQ, PQ, OHPQ and DCQ). It is located in the
acridine ring for ATB 1. We have been prevented by the multiple protonated state of pyronari-
dine, a relative of ATB and AQ, frommaking predictions about the physico-chemistry of that
drug, but we expect similar conclusions on relationship of VAR and LAR to activity to hold.
In addition to the resonance aspect for the drugs we have analysed, it is notable how the
increased flexibility of the meso form (RS) of DCQ base 6 allows a greater distance between the
quinoline rings on protonation compared with the RR and SS forms (Table 2) probably result-
ing in lesser mutual supression of protonation for the meso component.
Graphical approaches
We had originally observed for 8 structures an inverse, 2nd order polynomial relationship (qua-
dratic) between log LAR and log Resistance Index (log RI): y = 0.072x2-0.6675x + 1.7174, R2
was 0.8735) [13] and for the 12 structures examined here which include the less toxic early Ger-
man replacement for chloroquine, Sontochin (SC) (clinically tested on the North African bat-
tlefield, captured by the allies, and transferred to the US) and another 3-substituted CQ-related
structure, PH-203 (in development [20]) a similar quadratic equation (with HCQ classed as an
outlier) was observed (Fig 3).
y ¼ 0:07008  X2  0:6145x þ 1:489;
R2 ¼ 0:9706
Log LAR and log VAR clearly both have an influence on activity and in Fig 4, we detect an
inverse linear relationship between log (LAR/VAR) or log D(pHVAC) and log RI.
y ¼ 0:2178x þ 0:1774
R2 ¼ 0:6315
P ¼ 0:002
When the value of log (LAR/VAR) (or (log D(pHVAC)) increases, log Resistance index, RI,
approaches zero,. This indicates that both LAR and VAR are important, not surprising since a
Table 2. AM1 energies. Note reduced distance between N-1 and 4-amino N atoms in all the diprotonated forms and increased separation of quinolines N1
in tetraprotonated forms of DCQ.
AMI (rms 0.001) R&S R&S R&S PQ PQ2H+ PQ4+ R-DCQ,
S-
R-DCQ,S- R-DCQ,S- MESO- MESO- MESO-
CQ CQ1H+ CQ2H+ (N-1) DCQ DCQ (2H
+)
DCQ (4H
+)
RS-DCQ RS-DCQ N1-
2H+
RS-DCQ
4H+
Total energy kcal/mol -84345 -84513 -84650 -141613 -141941 -142025 -138676 -139012 -139065 -138675 -139010 -139071
HOF kcal/mol 23.65 170.2 347.9 126.7 428.8 974 106.2 400.7 977.4 107.9 402.1 971.3
distance between
quinolines N-1
NA NA NA 17.65Å 18.29Å 18.3Å 15.01Å 16.43Å 16.91Å 11.93Å 15.99Å 17.29Å
bridging sc N-N NA NA NA 4.985Å 4.965Å 5.073Å 2.986Å 2.985Å 3.036Å 2.952Å 2.983Å 3.019Å
quinoline N-1 7.893Å 7.999Å 8.991Å 6.526Å 6.827Å 6.83Å 6.038Å 6.992Å 7.0Å 7.585Å 6.806Å 7.662Å
to terminal sc-N 6.52Å 6.819Å 6.837Å 6.582Å 6.836Å 7.032Å 6.774Å 7.534Å 7.571Å
separation of N-1 4.255
Å
4.258
Å
4.196
Å
4.280 4.202 4.231 4.282 4.187 4.234 4.260 4.198 4.221
and 4-amino N 4.280 4.200 4.231 4.252 4.189 4.222 4.249 4.186 4.210
doi:10.1371/journal.pone.0160091.t002
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high drug concentration in the vacuolar water is important for inhibition of haematin dimer-
ization, and in resistance the CQ-exporter PfCRT is blocked and transport inhibited by the
hydrophobic concentrated drug from the vacuolar water. The equation for this linear regres-
sion, might therefore be used to predict log RI for a variety of pAP structural variants, where
the only physicochemical data available are the 2 log D values.
Fig 3. 2nd order polynomial for logRI (y) on Log LAR(x) for 11 p-aminopyridines and one outlier.
doi:10.1371/journal.pone.0160091.g003
Fig 4. Linear regression of log Resistance Index, (y) vs log (LAR/VAR), (x). (12 p-amino pyridines).
doi:10.1371/journal.pone.0160091.g004
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In view of the very high VAR values we predict for DCQ, this is in agreement with the high
liver localization noted at the start of its history [2, 3] and it may be regarded as fortunate that
such a highly lysosomotropic agent was not tested clinically on any scale.
Supporting Information
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